Journal of Infection
Volume 59, Supplement 1 , Pages S4-S16, September 2009

Infections caused by Gram-positive bacteria: a review of the global challenge

  • Neil Woodford

      Affiliations

    • Corresponding Author InformationCorresponding author. Dr. Neil Woodford. ARMRL, Centre for Infections, Health Protection Agency, 61 Colindale Ave., London NW9 5EQ, UK. Tel.: +44 (0)20 8327 7255; fax: +44 (0) 20 8327 6264
    • ,
  • David M. Livermore

Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London, UK

Article Outline

Summary 

Infections caused by multidrug-resistant Gram-positive bacteria represent a major public health burden, not just in terms of morbidity and mortality, but also in terms of increased expenditure on patient management and implementation of infection control measures. Staphylococcus aureus and Enterococcus spp. are established pathogens in the hospital environment, and their frequent multidrug resistance complicates therapy. The archetypal hospital “superbug”, methicillin-resistant S. aureus (MRSA), regularly attracts mass-media interest and, in many countries, there is political pressure to reduce MRSA infection rates, with some progress now being made in the United Kingdom and the United States. To compound these established problems, we have witnessed the emergence and spread of virulent clones of MRSA in the community, and of Clostridium difficile in hospitals. Multidrug-resistant Streptococcus pneumoniae clones are major community pathogens in many parts of the world, but are now being challenged by new conjugate vaccines. Using combinations of molecular epidemiological tools, which characterize the resistant isolates and their resistance determinants, scientists can track highly successful bacterial strains at local, national, and international levels. These methods have provided new insights into the evolution of key pathogens, and this information may aid the design of control strategies and vaccines. In addition, the development of new antimicrobials including oxazolidinones, lipopeptides, glycylcyclines, ketolides, and new generations of fluoroquinolones, antistaphylococcal b-lactams, and glycopeptides must remain a high priority for the continued effective treatment of infections caused by resistant strains. So far, resistance to these newer agents is identified rarely in surveillance programs, but occasional reports of resistance causing therapeutic failure (e.g., with linezolid, daptomycin, telithromycin, or newer fluoroquinolones) give cause for concern. The emergence of antibiotic resistance is inevitable, but we must seek to decrease its impact and prolong the effectiveness of the agents available to us.

Keywords:  Antibiotic resistance , Enterococcus , Pneumococcus , Staphylococcus

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Williams RE . Epidemic staphylococci . Lancet . 1959;1:190–195
  2. Jevons MP . “Celbenin”-resistant staphylococci . Br Med J . 1961;1:124–125
  3. Bogdanovich T , Ednie LM , Shapiro S , Appelbaum PC . Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin . Antimicrob Agents Chemother . 2005;49:4210–4219
  4. von Eiff C , Friedrich AW , Becker K , Peters G . Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes . Antimicrob Agents Chemother . 2005;49:4372–4374
  5. Chongtrakool P , Ito T , Ma XX , Kondo Y , Trakulsomboon S , Tiensasitorn C , et al.   Staphylococcal cassette chromosome mec (SCC mec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements . Antimicrob Agents Chemother . 2006;50:1001–1012
  6. Zhang K , McClure JA , Elsayed S , Conly JM . Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother . 2009;53:531–540
  7. Deurenberg RH , Stobberingh EE . The evolution of Staphylococcus aureus . Infect Genet Evol . 2008;8:747–763
  8. Hiramatsu K , Cui L , Kuroda M , Ito T . The emergence and evolution of methicillin-resistant Staphylococcus aureus . Trends Microbiol . 2001;9:486–493
  9. Oliveira DC , Tomasz A , De Lencastre H . The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements . Microb Drug Resist . 2001;7:349–361
  10. Oliveira DC , Tomasz A , De Lencastre H . Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillinresistant Staphylococcus aureus . Lancet Infect Dis . 2002;2:180–189
  11. Ito T , Ma XX , Takeuchi F , Okuma K , Yuzawa H , Hiramatsu K . Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC . Antimicrob Agents Chemother . 2004;48:2637–2651
  12. Hiramatsu K , Kondo N , Ito T . Genetic basis for molecular epidemiology of MRSA . J Infect Chemother . 1996;2:117–129
  13. Huletsky A , Giroux R , Rossbach V , Gagnon M , Vaillancourt M , Bernier M , et al.   New real-time PCR assay for rapid detection of methicillinresistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci . J Clin Microbiol . 2004;42:1875–1884
  14. Huletsky A , Lebel P , Picard FJ , Bernier M , Gagnon M , Boucher N , et al.   Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program . Clin Infect Dis . 2005;40:976–981
  15. Warren DK , Liao RS , Merz LR , Eveland M , Dunne WM . Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay . J Clin Microbiol . 2004;42:5578–5581
  16. Wu S , Piscitelli C , De Lancastre H , Tomasz A . Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin-susceptible strain of Staphylococcus sciuri . Microb Drug Resist . 1996;2:435–441
  17. Severin A , Wu SW , Tabei K , Tomasz A . High-level β-lactam resistance and cell wall synthesis catalyzed by the mecA homologue of Staphylococcus sciuri introduced into Staphylococcus aureus . J Bacteriol . 2005;187:6651–6658
  18. Enright MC , Robinson DA , Randle G , Feil EJ , Grundmann H , Spratt BG . The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) . Proc Natl Acad Sci USA . 2002;99:7687–7692
  19. Deplano A , Tassios PT , Glupczynski Y , Godfroid E , Struelens MJ . In vivo deletion of the methicillin resistance mec region from the chromosome of Staphylococcus aureus strains . J Antimicrob Chemother . 2000;46:617–620
  20. Donnio PY , Oliveira DC , Faria NA , Wilhelm N , Le Coustumier A , de Lencastre H . Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphylococcus aureus . J Clin Microbiol . 2005;43:4191–4193
  21. Kerr S , Kerr GE , Mackintosh CA , Marples RR . A survey of methicillinresistant Staphylococcus aureus affecting patients in England and Wales . J Hosp Infect . 1990;16:35–48
  22. Zierdt CH , Robertson EA , Williams RL , MacLowry JD . Computer analysis of Staphylococcus aureus phage typing data from 1957 to 1975, citing epidemiological trends and natural evolution within the phage typing system . Appl Environ Microbiol . 1980;39:623–629
  23. Richardson JF , Chittasobhon N , Marples RR . Supplementary phages for the investigation of strains of methicillin-resistant Staphylococcus aureus . J Med Microbiol . 1988;25:67–74
  24. Walker J , Borrow R , Goering RV , Egerton S , Fox AJ , Oppenheim BA . Subtyping of methicillin-resistant Staphylococcus aureus isolates from the North-West of England: a comparison of standardised pulsedfield gel electrophoresis with bacteriophage typing including an interlaboratory reproducibility study . J Med Microbiol . 1999;48:297–301
  25. McDougal LK , Steward CD , Killgore GE , Chaitram JM , McAllister SK , Tenover FC . Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database . J Clin Microbiol . 2003;41:5113–5120
  26. Murchan S , Aucken HM , O'neill GL , Ganner M , Cookson BD . Emergence, spread, and characterization of phage variants of epidemic methicillinresistant Staphylococcus aureus 16 in England and Wales . J Clin Microbiol . 2004;42:5154–5160
  27. Enright MC , Day NP , Davies CE , Peacock SJ , Spratt BG . Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus . J Clin Microbiol . 2000;38:1008–1015
  28. Enright MC , Spratt BG . Multilocus sequence typing . Trends Microbiol . 1999;7:482–487
  29. Johnson AP , Aucken HM , Cavendish S , Ganner M , Wale MJ , Warner M , et al.   Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: Analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS) . J Antimicrob Chemother . 2001;48:143–144
  30. Johnson AP , Pearson A , Duckworth G . Surveillance and epidemiology of MRSA bacteraemia in the UK . J Antimicrob Chemother . 2005;56:455–462
  31. Wannet WJ , Spalburg E , Heck ME , Pluister GN , Willems RJ , de Neeling AJ . Widespread dissemination in The Netherlands of the epidemic Berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin . J Clin Microbiol . 2004;42:3077–3082
  32. Wertheim HF , Vos MC , Boelens HA , Voss A , Vandenbroucke-Grauls CM , Meester MH , et al.   Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use . J Hosp Infect . 2004;56:321–325
  33. Wulf M , Voss A . MRSA in livestock animals an epidemic waiting to happen? . Clin Microbiol Infect . 2008;14:519–521
  34. van Belkum A , Melles DC , Peeters JK , Van Leeuwen WB , van Duijkeren E , Huijsdens XW , et al.   Methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398 in pigs and humans . Emerg Infect Dis . 2008;14:479–483
  35. Wulf MW , Markestein A , van der Linden FT , Voss A , Klaassen C , Verduin CM . First outbreak of methicillin-resistant Staphylococcus aureus ST398 in a Dutch hospital, June 2007 . Euro Surveill . 2008;13(9): Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8051 Published online February 28, 2008. Accessed March 13, 2009.
  36. Draghi DC , Sheehan DJ , Hogan P , Sahm DF . In vitro activity of linezolid against key Gram-positive organisms isolated in the United States: results of the LEADER 2004 surveillance program . Antimicrob Agents Chemother . 2005;49:5024–5032
  37. Jones RN , Ross JE , Castanheira M , Mendes RE . United States resistance surveillance results for linezolid (LEADER Program for 2007) . Diagn Microbiol Infect Dis . 2008;62:416–426
  38. Weber JT . Community-associated methicillin-resistant Staphylococcus aureus . Clin Infect Dis . 2005;41(Suppl 4):S269–S272
  39. Zetola N , Francis JS , Nuermberger EL , Bishai WR . Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat . Lancet Infect Dis . 2005;5:275–286
  40. Diederen BM , Kluytmans JA . The emergence of infections with community-associated methicillin resistant Staphylococcus aureus . J Infect . 2005;52:157–168
  41. Morgan M . Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia . Br Med J . 2005;331:793–794
  42. Vandenesch F , Naimi T , Enright MC , Lina G , Nimmo GR , Heffernan H , et al.   Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence . Emerg Infect Dis . 2003;9:978–984
  43. Robinson DA , Kearns AM , Holmes A , Morrison D , Grundmann H , Edwards G , et al.   Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone . Lancet . 2005;365:1256–1258
  44. Tenover FC , McDougal LK , Goering RV , Killgore G , Projan SJ , Patel JB , et al.   Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States . J Clin Microbiol . 2006;44:108–118
  45. Diep BA , Gill SR , Chang RF , Phan TH , Chen JH , Davidson MG , et al.   Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus . Lancet . 2006;367:731–739
  46. Enright MC . Genome of an epidemic community-acquired MRSA . Lancet . 2006;367:705–706
  47. Naas T , Fortineau N , Spicq C , Robert J , Jarlier V , Nordmann P . Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital . J Hosp Infect . 2005;61:321–329
  48. Kourbatova EV , Halvosa JS , King MD , Ray SM , White N , Blumberg HM . Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections . Am J Infect Control . 2005;33:385–391
  49. Seybold U , Kourbatova EV , Johnson JG , Halvosa SJ , Wang YF , King MD , et al.   Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections . Clin Infect Dis . 2006;42:647–656
  50. Roberts JC , Cannons AC , Amuso PT , Cattani J . Virtual digest identification of secondary enzymes for use in pulsed-field gel electrophoresis of Staphylococcus aureus . J Microbiol Methods . 2006;66:362–368
  51. Shopsin B , Gomez M , Montgomery SO , Smith DH , Waddington M , Dodge DE , et al.   Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains . J Clin Microbiol . 1999;37:3556–3563
  52. Hiramatsu K , Hanaki H , Ino T , Yabuta K , Oguri T , Tenover FC . Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility . J Antimicrob Chemother . 1997;40:135–136
  53. Ploy MC , Grelaud C , Martin C , de Lumley L , Denis F . First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital . Lancet . 1998;351:1212
  54. Martin R , Wilcox KR . Staphylococcus aureus with reduced susceptibility to vancomycin United States, 1997 . MMWR Morb Mortal Wkly Rep . 1997;46:765–766
  55. Bierbaum G , Fuchs K , Lenz W , Szekat C , Sahl H-G . Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany . Eur J Clin Microbiol Infect Dis . 1999;18:691–696
  56. Cui L , Ma X , Sato K , Okuma K , Tenover FC , Mamizuka EM , et al.   Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus . J Clin Microbiol . 2003;41:5–14
  57. Hanaki H , Labischinski H , Inaba Y , Kondo N , Murakami H , Hiramatsu K . Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50 . J Antimicrob Chemother . 1998;42:315–320
  58. Cui L , Murakami H , Kuwahara-Arai K , Hanaki H , Hiramatsu K . Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 . Antimicrob Agents Chemother . 2000;44:2276–2285
  59. Hiramatsu K . Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance . Lancet Infect Dis . 2001;1:147–155
  60. Wootton M , Avison MB , Bennett PM , Howe RA , MacGowan AP , Walsh TR . Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA . J Antimicrob Chemother . 2004;53:406–407
  61. Sakoulas G , Eliopoulos GM , Moellering RC , Wennersten C , Venkataraman L , Novick RP , et al.   Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin . Antimicrob Agents Chemother . 2002;46:1492–1502
  62. Cui L , Neoh Hm , Shoji M , Hiramatsu K . Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus . Antimicrob Agents Chemother . 2009;53:1231–1234
  63. Sievert DM , Boulton ML , Stoltman G , Johnson D , Stobierski MG , Downes FP , et al.   Staphylococcus aureus resistant to vancomycin United States, 2002 . MMWR Morb Mortal Wkly Rep . 2002;51:565–567
  64. Sievert DM , Rudrik JT , Patel JB , McDonald LC , Wilkins MJ , Hageman JC . Vancomycin-resistant Staphylococcus aureus in the United States, 2002 2006 . Clin Infect Dis . 2008;46:668–674
  65. Tenover FC , Weigel LM , Appelbaum PC , McDougal LK , Chaitram J , McAllister S , et al.   Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania . Antimicrob Agents Chemother . 2004;48:275–280
  66. CDC  . Vancomycin-resistant Staphylococcus aureus New York, 2004 . MMWR Morb Mortal Wkly Rep . 2004;53:322–323
  67. Clark NC , Weigel LM , Patel JB , Tenover FC . Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania . Antimicrob Agents Chemother . 2005;49:470–472
  68. Perichon B , Courvalin P . Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother . 2004;48:4281–4285
  69. Saha B , Singh AK , Ghosh A , Bal M . Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia) . J Med Microbiol . 2008;57:72–79
  70. Aligholi M , Emaneini M , Jabalameli F , Shahsavan S , Dabiri H , Sedaght H . Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran . Med Princ Pract . 2008;17:432–434
  71. Hope R , Livermore DM , Brick G , Lillie M , Reynolds R  on behalf of the BSAC Working Parties on Resistance Surveillance . Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001 06 . J Antimicrob Chemother . 2008;62(Suppl 2):ii65–ii74
  72. Murray BE . The life and times of the enterococcus . Clin Microbiol Rev . 1990;3:46–65
  73. Moellering RCJ . The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options . J Antimicrob Chemother . 1991;28:1–12
  74. Carias LL , Rudin SD , Donskey CJ , Rice LB . Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate . J Bacteriol . 1998;180:4426–4434
  75. Rice LB , Carias LL , Rudin S , Lakticova V , Wood A , Hutton-Thomas R . Enterococcus faecium low-affinity pbp5 is a transferable determinant . Antimicrob Agents Chemother . 2005;49:5007–5012
  76. Zscheck KK , Murray BE . Nucleotide sequence of the β-lactamase gene from Enterococcus faecalis HH22 and its similarity to staphylococcal β-lactamase genes . Antimicrob Agents Chemother . 1991;35:1736–1740
  77. Murray BE . β-Lactamase-producing enterococci . Antimicrob Agents Chemother . 1992;36:2355–2359
  78. Coudron P , Markowitz SM , Wong ES . Isolation of a β-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium . Antimicrob Agents Chemother . 1992;36:1125–1126
  79. Murray BE , Church DA , Wanger A , Zscheck K , Levison ME , Ingerman MJ , et al.   Comparison of two β-lactamase-producing strains of Streptococcus faecalis . Antimicrob Agents Chemother . 1986;30:861–864
  80. Murray BE , An FY , Clewell DB . Plasmids and pheromone response of the β-lactamase producer Streptococcus (Enterococcus) faecalis HH22 . Antimicrob Agents Chemother . 1988;32:547–551
  81. Rhinehart E , Smith NE , Wennersten C , Gorss E , Freeman J , Eliopoulos GM , et al.   Rapid dissemination of β-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward . N Engl J Med . 1990;323:814–818
  82. Murray BE , Singh KV , Markowitz SM , Lopardo HA , Patterson JE , Zervos MJ , et al.   Evidence for clonal spread of a single strain of β-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states . J Infect Dis . 1991;163:780–785
  83. Patterson JE , Singh KV , Murray BE . Epidemiology of an epidemic strain of β-lactamase-producing Enterococcus faecalis . J Clin Microbiol . 1991;29:2513–2516
  84. Murray BE , Lopardo HA , Rubeglio E , Frosolono M , Singh KV . Intrahospital spread of a single gentamicin-resistant, β-lactamase-producing strain of Enterococcus faecalis in Argentina . Antimicrob Agents Chemother . 1992;36:230–232
  85. Rice LB , Eliopoulos GM , Wennersten C , Goldmann D , Jacoby G , Moellering RC . Chromosomally-mediated β-lactamase production and gentamicin resistance in Enterococcus faecalis . Antimicrob Agents Chemother . 1991;35:272–276
  86. Rice LB , Marshall SH . Evidence of incorporation of the chromosomal β-lactamase gene of Enterococcus faecalis CH19 into a transposon derived from staphylococci . Antimicrob Agents Chemother . 1992;36:1843–1846
  87. Woodford N . Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci . Clin Microbiol Infect . 2005;11(Suppl 3):2–21
  88. Brown DFJ , Hope R , Livermore DM , Brick G , Broughton K , George RC , et al.   Non-susceptibility trends among enterococci and nonpneumococcal streptococci from bacteraemias in the UK and Ireland, 2001 06 . J Antimicrob Chemother . 2008;62(Suppl 2):ii75–ii85
  89. Werner G , Coque TM , Hammerum AM , Hope R , Hryniewicz W , Johnson A , et al.   Emergence and spread of vancomycin resistance among enterococci in Europe . Euro Surveill . 2008;13(47): Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19046 Published online November 20, 2008. Accessed March 13, 2009.
  90. Woodford N , Chadwick PR , Morrison D , Cookson BD . Strains of glycopeptide-resistant Enterococcus faecium can alter their van genotypes during an outbreak . J Clin Microbiol . 1997;35:2966–2968
  91. Boyd DA , Willey BM , Fawcett D , Gillani N , Mulvey MR . Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala D-Ser gene cluster, vanL . Antimicrob Agents Chemother . 2008;52:2667–2672
  92. Woodford N . Novel agents for the treatment of resistant Gram-positive infections . Expert Opin Investig Drugs . 2003;12:117–137
  93. Akins RL , Rybak MJ . Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations . Antimicrob Agents Chemother . 2001;45:454–459
  94. Livermore DM . Future directions with daptomycin . J Antimicrob Chemother . 2008;62(Suppl 3):iii41–iii49
  95. Mercier RC , Stumpo C , Rybak MJ . Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium . J Antimicrob Chemother . 2002;50:19–24
  96. Pace JL , Judice JK . Telavancin (Theravance) . Curr Opin Investig Drugs . 2005;6:216–225
  97. Tenover FC , Arbeit RD , Goering RV , Mickelsen PA , Murray BE , Persing DH , et al.   Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing . J Clin Microbiol . 1995;33:2233–2239
  98. Morrison D , Woodford N , Barrett SP , Sisson P , Cookson BD . DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains . J Clin Microbiol . 1999;37:1084–1091
  99. Morrison D , Woodford N , Cookson BD . Epidemic vancomycin-resistant Enterococcus faecium in the UK . Clin Microbiol Infect . 1996;1:146–147
  100. Chadwick P , Oppenheim BA , Fox A , Woodford N , Morgenstern GR , Scarffe JH . Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit . J Hosp Infect . 1996;34:171–182
  101. Nelson RR , McGregor KF , Brown AR , Amyes SG , Young H . Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period . J Clin Microbiol . 2000;38:2112–2116
  102. Woodford N , Reynolds R , Turton J , Scott F , Sinclair A , Williams A , et al.   Two widely disseminated strains of Enterococcus faecalis highly resistant to gentamicin and ciprofloxacin from bacteraemias in the UK and Ireland . J Antimicrob Chemother . 2003;52:711–714
  103. Hallgren A , Saeedi B , Nilsson M , Monstein HJ , Isaksson B , Hanberger H , et al.   Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units . J Antimicrob Chemother . 2003;52:162–167
  104. Jett BD , Huycke MM , Gilmore MS . Virulence in enterococci . Clin Microbiol Rev . 1994;7:462–478
  105. Homan WL , Tribe D , Poznanski S , Li M , Hogg G , Spalburg E , et al.   Multilocus sequence typing scheme for Enterococcus faecium . J Clin Microbiol . 2002;40:1963–1971
  106. Ruiz-Garbajosa P, Nallapareddy SR, Murray BE, Bonten MJ, Top J, Coque T, et al. Enterococcus faecalis population structure. In: Proceedings & Abstracts of the 2nd International ASM FEMS Conference on Enterococci, Helsingør, Denmark; 2005, Abstract B4.
  107. Willems RJ , Top J , van Santen M , Robinson DA , Coque TM , Baquero F , et al.   Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex . Emerg Infect Dis . 2005;11:821–828
  108. Leavis HL , Willems RJL , Top J , Bonten MJM . High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium . J Clin Microbiol . 2006;44:1059–1064
  109. Farrell DJ , Felmingham D , Shackcloth J , Williams L , Maher K , Hope R , et al.   Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007 . J Antimicrob Chemother . 2008;62(Suppl 2):ii87–ii95
  110. Jenkins SG , Farrell DJ , Patel M , Lavin BS . Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000 2003: PROTEKT US years 1 3 . J Infect . 2005;51:355–363
  111. Jenkins SG , Brown SD , Farrell DJ . Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1 4 . Ann Clin Microbiol Antimicrob . 2008;7:1
  112. McGee L , McDougal L , Zhou J , Spratt BG , Tenover FC , George R , et al.   Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network . J Clin Microbiol . 2001;39:2565–2571
  113. Bronzwaer SL , Cars O , Buchholz U , Molstad S , Goettsch W , Veldhuijzen IK , et al.   A European study on the relationship between antimicrobial use and antimicrobial resistance . Emerg Infect Dis . 2002;8:278–282
  114. Wise R . The relentless rise of resistance? . J Antimicrob Chemother . 2004;54:306–310
  115. Porat N , Barkai G , Jacobs MR , Trefler R , Dagan R . Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel . J Infect Dis . 2004;189:385–392
  116. Dowson CG , Hutchison A , Woodford N , Johnson AP , George RC , Spratt BG . Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae . Proc Natl Acad Sci USA . 1990;87:5858–5862
  117. Coffey TJ , Dowson CG , Daniels M , Spratt BG . Horizontal spread of an altered penicillin-binding protein 2B gene between Streptococcus pneumoniae and Streptococcus oralis . FEMS Microbiol Lett . 1993;110:335–339
  118. Dowson CG , Coffey TJ , Kell C , Whiley RA . Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae . Mol Microbiol . 1993;9:635–643
  119. Beall B , McEllistrem MC , Gertz RE , Wedel S , Boxrud DJ , Gonzalez AL , et al.   Pre-and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002 . J Clin Microbiol . 2006;44:999–1017
  120. Medina MJ , Greene CM , Gertz RE , Facklam RR , Jagero G , Hamel M , et al.   Novel antibiotic-resistant pneumococcal strains recovered from the upper respiratory tracts of HIV-infected adults and their children in Kisumu, Kenya . Microb Drug Resist . 2005;11:9–17
  121. Jefferies JMC , Smith A , Clarke SC , Dowson C , Mitchell TJ . Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching . J Clin Microbiol . 2004;42:5681–5688
  122. Beall B , McEllistrem MC , Gertz RE , Boxrud DJ , Besser JM , Harrison LH , et al.   Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States . J Infect Dis . 2002;186:118–122
  123. Henriqus NB , Christensson B , Sandgren A , Noreen B , Sylvan S , Burman LG , et al.   Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers . Microb Drug Resist . 2003;9:337–344
  124. Dagan R , Klugman KP . Impact of conjugate pneumococcal vaccines on antibiotic resistance . Lancet Infect Dis . 2008;8:785–795
  125. Van Valen L . A new evolutionary law . Evolutionary Theory . 1973;1:1–30
  126. Reynolds R , Potz N , Colman M , Williams A , Livermore D , MacGowan A . Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001 2002: the BSAC Bacteraemia Resistance Surveillance Programme . J Antimicrob Chemother . 2004;53:1018–1032
  127. Tsiodras S , Gold HS , Sakoulas G , Eliopoulos GM , Wennersten C , Venkataraman L , et al.   Linezolid resistance in a clinical isolate of Staphylococcus aureus . Lancet . 2001;358:207–208
  128. Machado ARL, Andrade SS, Barth AL, Lutz L, Sader HS, Gales AC. The emergence of linezolid-resistance among Staphylococcus aureus from cystic fibrosis patients. In: Proceedings & Abstracts of the 43rd Interscience Conference on Antimicrobial Agents & Chemotherapy, Chicago, IL. American Society for Microbiology; 2003, Abstract C2-1825.
  129. Meka VG , Pillai SK , Sakoulas G , Wennersten C , Venkataraman L , DeGirolami PC , et al.   Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA . J Infect Dis . 2004;190:311–317
  130. North SE , Ellington MJ , Johnson AP , Livermore DM , Woodford N . In vitro selection of linezolid resistance in hypermutable and wild-type Staphylococcus aureus . Clin Microbiol Infect . 2005;11(Suppl 2):299; Abstract P974.
  131. North SE, Ellington MJ, Johnson AP, Livermore DM, Woodford N. Chloramphenicol-selected mutants of Staphylococcus aureus may show cross-resistance to linezolid. In: Proceedings & Abstracts of the 45th Interscience Conference on Antimicrobial Agents & Chemotherapy, Washington, DC. American Society for Microbiology; 2005, Abstract C1-1417.
  132. North SE, Ellington MJ, Johnson AP, Livermore DM, Woodford N. Novel pyrosequencing assays to detect T2500A and other mutations conferring linezolid resistance in Staphylococcus aureus. In: Proceedings & Abstracts of the 45th Interscience Conference on Antimicrobial Agents & Chemotherapy, Washington, DC. American Society for Microbiology; 2005, Abstract C2-272.
  133. Wilson P , Andrews JA , Charlesworth R , Walesby R , Singer M , Farrell DJ , et al.   Linezolid resistance in clinical isolates of Staphylococcus aureus . J Antimicrob Chemother . 2003;51:186–188
  134. Hill RLR, Kearns AM, Nash J, North SE, Pike R, Newson T, et al. Linezolid-resistant ST36 MRSA from two paediatric cystic fibrosis patients, following prolonged treatment. In: Proceedings & Abstracts of the 45th Interscience Conference on Antimicrobial Agents & Chemotherapy, Washington, DC. American Society for Microbiology; 2005, Abstract C2-273.
  135. Fraimow HS, Knob C, Mazur W, McNutt S. Unsuspected emergence of linezolid resistance in coagulase negative staphylococci in a University Hospital. In: Proceedings & Abstracts of the 45th Interscience Conference on Antimicrobial Agents & Chemotherapy, Washington, DC. American Society for Microbiology; 2005, Abstract C2-271.
  136. Zurenko GE, Todd WM, Hafkin B, Myers B, Kaufmann C, Bock J, et al. Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid. In: Proceedings & Abstracts of the 39th Interscience Conference on Antimicrobial Agents & Chemotherapy, San Francisco, CA. American Society for Microbiology; 1999, Abstract 848.
  137. Gonzales RD , Schreckenberger PC , Graham MB , Kelkar S , DenBesten K , Quinn JP . Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid . Lancet . 2001;357:1179
  138. Auckland C , Teare L , Cooke F , Kaufmann ME , Warner M , Jones G , et al.   Linezolid-resistant enterococci: report of the first isolates in the United Kingdom . J Antimicrob Chemother . 2002;50:743–746
  139. Johnson AP , Tysall L , Stockdale MW , Woodford N , Kaufmann ME , Warner M , et al.   Emerging linezolid resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit . Eur J Clin Microbiol Infect Dis . 2002;21:751–754
  140. Halle E , Padberg J , Rosseau S , Klare I , Werner G , Witte W . Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany . Infection . 2004;32:182–183
  141. Herrero IA , Issa NC , Patel R . Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium . N Engl J Med . 2002;346:867–869
  142. Engemann JJ, Joyce MJ, Harrell LJ, Evans SA, Reller LB, Sexton m DJ, et al. Outbreak of linezolid-resistant Enterococcus faecium bloodstream infections on an oncology ward. In: Proceedings & Abstracts of the 43rd Interscience Conference on Antimicrobial Agents & Chemotherapy, Chicago, IL. American Society for Microbiology; 2003, Abstract K-1112.
  143. Prystowsky J , Siddiqui F , Chosay J , Shinabarger DL , Millichap J , Peterson LR , et al.   Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci . Antimicrob Agents Chemother . 2001;45:2154–2156
  144. Lobritz M , Hutton-Thomas R , Marshall S , Rice LB . Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis . Antimicrob Agents Chemother . 2003;47:3318–3320
  145. Marshall SH , Donskey CJ , Hutton-Thomas R , Salata RA , Rice LB . Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis . Antimicrob Agents Chemother . 2002;46:3334–3336
  146. Mazur W, Knob C, Fraimow HS. Quantification of 23S rRNA mutations and relative fitness of clinical isolates of linezolid-resistant Enterococcus faecalis. In: Proceedings & Abstracts of the 42nd Interscience Conference on Antimicrobial Agents & Chemotherapy, San Diego, CA. American Society for Microbiology; 2002, Abstract C1-1607.
  147. Sinclair A , Arnold C , Woodford N . Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in enterococci . Antimicrob Agents Chemother . 2003;47:3620–3622
  148. Ruggero KA , Schroeder LK , Schreckenberger PC , Mankin AS , Quinn JP . Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs . Diagn Microbiol Infect Dis . 2003;47:511–513
  149. Meka VG , Gold HS , Cooke A , Venkataraman L , Eliopoulos GM , Moellering RC , et al.   Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus . J Antimicrob Chemother . 2004;54:818–820
  150. Wolter N , Smith AM , Farrell DJ , Schaffner W , Moore M , Whitney CG , et al.   Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus . Antimicrob Agents Chemother . 2005;49:3554–3557
  151. Long KS , Poehlsgaard J , Kehrenberg C , Schwarz S , Vester B . The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics . Antimicrob Agents Chemother . 2006;50:2500–2505
  152. Kehrenberg C , Schwarz S . Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates . Antimicrob Agents Chemother . 2006;50:1156–1163
  153. Kehrenberg C , Cuny C , Strommenger B , Schwarz S , Witte W . Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr . Antimicrob Agents Chemother . 2009;53:779–781
  154. Toh SM , Xiong L , Arias CA , Villegas MV , Lolans K , Quinn J , et al.   Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid . Mol Microbiol . 2007;64:1506–1514
  155. Mendes RE , Deshpande LM , Castanheira M , DiPersio J , Saubolle MA , Jones RN . First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States . Antimicrob Agents Chemother . 2008;52:2244–2246
  156. Cui L , Tominaga E , Neoh Hm , Hiramatsu K . Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus . Antimicrob Agents Chemother . 2006;50:1079–1082
  157. Camargo ILBdC , Neoh Hm , Cui L , Hiramatsu K . Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype . Antimicrob Agents Chemother . 2008;52:4289–4299
  158. Mangili A , Bica I , Snydman DR , Hamer DH . Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia . Clin Infect Dis . 2005;40:1058–1060
  159. Hayden MK , Rezai K , Hayes RA , Lolans K , Quinn JP , Weinstein RA . Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus . J Clin Microbiol . 2005;43:5285–5287
  160. Vikram HR , Havill NL , Koeth LM , Boyce JM . Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin . J Clin Microbiol . 2005;43:5384–5387
  161. Marty FM , Yeh WW , Wennersten CB , Venkataraman L , Albano E , Alyea EP , et al.   Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis . J Clin Microbiol . 2006;44:595–597
  162. Skiest DJ . Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin . J Clin Microbiol . 2006;44:655–656
  163. Sabol K , Patterson JE , Lewis JS , Owens A , Cadena J , Jorgensen JH . Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy . Antimicrob Agents Chemother . 2005;49:1664–1665
  164. Steenbergen JN , Alder J , Thorne GM , Tally FP . Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections . J Antimicrob Chemother . 2005;55:283–288
  165. Hobbs JK , Miller K , O'Neill AJ , Chopra I . Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus . J Antimicrob Chemother . 2008;62:1003–1008
  166. D'Costa VM , McGrann KM , Hughes DW , Wright GD . Sampling the antibiotic resistome . Science . 2006;311:374–377
  167. Werner G , Gfrorer S , Fleige C , Witte W , Klare I . Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient . J Antimicrob Chemother . 2008;61:1182–1183
  168. Johnson AP , Sheppard CL , Harnett SJ , Birtles A , Harrison TG , Brenwald NP , et al.   Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England . J Antimicrob Chemother . 2003;52:953–960
  169. Ho PL , Que TL , Chiu SS , Yung RW , Ng TK , Tsang DN , et al.   Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995 2001 . Emerg Infect Dis . 2004;10:1250–1257
  170. Farrell DJ , Felmingham D . The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae . J Antimicrob Chemother . 2005;56:795–797
  171. Rantala M , Haanpera-Heikkinen M , Lindgren M , Seppala H , Huovinen P , Jalava J , et al.   Streptococcus pneumoniae isolates resistant to telithromycin . Antimicrob Agents Chemother . 2006;50:1855–1858
  172. Wilcox MH . Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis . Best Pract Res Clin Gastroenterol . 2003;17:475–493
  173. Kuijper EJ , van Dissel JT , Wilcox MH . Clostridium difficile: changing epidemiology and new treatment options . Curr Opin Infect Dis . 2007;20:376–383
  174. Kuijper EJ , Barbut F , Brazier JS , Kleinkauf N , Eckmanns T , Lambert ML , et al.   Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008 . Euro Surveill . 2008;13(31): Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18942 Published online July 31, 2008. Accessed March 13, 2009.
  175. Warny M , Pepin J , Fang A , Killgore G , Thompson A , Brazier J , et al.   Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe . Lancet . 2005;366:1079–1084
  176. McDonald LC , Killgore GE , Thompson A , Owens RC , Kazakova SV , Sambol SP , et al.   An epidemic, toxin gene-variant strain of Clostridium difficile . N Engl J Med . 2005;353:2433–2441
  177. Louie TJ . How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile? . CMAJ . 2005;173:1049–1050

PII: S0163-4453(09)60003-7

doi:10.1016/S0163-4453(09)60003-7

Journal of Infection
Volume 59, Supplement 1 , Pages S4-S16, September 2009

Article Tools